Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3923730)

Published in J Transl Med on February 07, 2014

Authors

Sophie Le Lamer, Stéphanie Paradis, Hidayat Rahmouni, Corinne Chaimbault, Magali Michaud, Marcel Culcasi, Jean Afxantidis, Mathilde Latreille, Patrick Berna, Alain Berdeaux, Sylvia Pietri, Didier Morin, Yves Donazzolo, Jean-Louis Abitbol, Rebacca M Pruss, Sophie Schaller1

Author Affiliations

1: Trophos, Luminy Biotech Entreprises, Case 931, 13288 Marseille Cedex 9, France. sschaller@trophos.com.

Associated clinical trials:

Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction | NCT01374321

Articles cited by this

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med (1992) 18.74

Myocardial reperfusion injury. N Engl J Med (2007) 13.41

Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med (2008) 9.40

Postconditioning the human heart. Circulation (2005) 4.35

Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J (1988) 3.41

Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans (2006) 2.57

Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol (2009) 1.98

Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology (2005) 1.95

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann Oncol (2003) 1.63

Time to take myocardial reperfusion injury seriously. N Engl J Med (2008) 1.20

The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol (2001) 1.16

Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction. Am J Physiol Heart Circ Physiol (2000) 1.12

Inhibition of mitochondrial permeability transition pore opening: translation to patients. Cardiovasc Res (2009) 1.05

Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome. Nanomedicine (2011) 1.03

Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles. J Liposome Res (2007) 1.02

The radical trap 5,5-dimethyl-1-pyrroline N-oxide exerts dose-dependent protection against myocardial ischemia-reperfusion injury through preservation of mitochondrial electron transport. J Pharmacol Exp Ther (2009) 1.02

TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition. J Pharmacol Exp Ther (2010) 0.99

Heart protection and radical trapping by DMPO during reperfusion in isolated working rat hearts. Free Radic Biol Med (1990) 0.98

Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues. Cardiovasc Res (2009) 0.94

Rationale and design of the 'MITOCARE' Study: a phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Cardiology (2012) 0.93

Mitochondrial calcium in health and disease. Biochim Biophys Acta (2009) 0.88

Peripheral benzodiazepine receptor-induced myocardial protection is mediated by inhibition of mitochondrial membrane permeabilization. J Pharmacol Exp Ther (2007) 0.88

Myocardial cell protection : a challenging time for action and a challenging time for clinical research. Circulation (2000) 0.85

AMISTAD trials: possible reasons for lack of success. J Am Coll Cardiol (2006) 0.84

Ascorbyl free radical as a reliable indicator of free-radical-mediated myocardial ischemic and post-ischemic injury. A real-time continuous-flow ESR study. Eur J Biochem (1990) 0.82

Liposome-mediated triggering of complement cascade. J Liposome Res (2008) 0.81

New perspectives on the cardioprotective phosphonate effect of the spin trap 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide: an hemodynamic and 31P NMR study in rat hearts. Free Radic Biol Med (1999) 0.81

Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery. Cardiovasc Drugs Ther (1997) 0.80

Cardiac protection takes off. Cardiovasc Res (2009) 0.77

Articles by these authors

Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J Pharmacol Exp Ther (2007) 1.55

Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Res (2009) 1.46

Supraspinal locomotor centers do/do not contribute significantly to the hyperpnea of dynamic exercise in humans. J Appl Physiol (1985) (2006) 1.42

Evaluation of the effects of therapeutic and supratherapeutic doses of agomelatine on the QT/QTc interval: a phase I, randomized, double-blind, placebo-controlled and positive-controlled, crossover thorough QT/QTc study conducted in healthy volunteers. J Cardiovasc Pharmacol (2014) 1.39

Hypothermic Total Liquid Ventilation Is Highly Protective Through Cerebral Hemodynamic Preservation and Sepsis-Like Mitigation After Asphyxial Cardiac Arrest. Crit Care Med (2015) 1.39

Propriospinal circuitry underlying interlimb coordination in mammalian quadrupedal locomotion. J Neurosci (2005) 1.28

Heart rate reduction during exercise-induced myocardial ischaemia and stunning. Eur Heart J (2004) 1.26

Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol (2008) 1.25

Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. Br J Clin Pharmacol (2009) 1.24

Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol Cell Biol (2007) 1.22

Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore. J Pharmacol Exp Ther (2008) 1.19

Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers. Patient Prefer Adherence (2010) 1.17

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults. Vaccine (2013) 1.11

Locomotor rhythmogenesis in the isolated rat spinal cord: a phase-coupled set of symmetrical flexion extension oscillators. J Physiol (2007) 1.10

Coordinated network functioning in the spinal cord: an evolutionary perspective. J Physiol Paris (2007) 1.09

H11 kinase/heat shock protein 22 deletion impairs both nuclear and mitochondrial functions of STAT3 and accelerates the transition into heart failure on cardiac overload. Circulation (2011) 1.09

A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species. Free Radic Biol Med (2011) 1.08

After the London tragedy, is it still possible to consider Phase I is safe? Br J Clin Pharmacol (2006) 1.08

Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise. Am J Physiol Heart Circ Physiol (2002) 1.06

A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia. FASEB J (2008) 1.06

Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine. Hum Vaccin (2010) 1.05

Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs. J Pharmacol Exp Ther (2003) 1.05

Plastid alternative oxidase (PTOX) promotes oxidative stress when overexpressed in tobacco. J Biol Chem (2009) 0.99

TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition. J Pharmacol Exp Ther (2010) 0.99

Contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am J Physiol Heart Circ Physiol (2002) 0.99

Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction. Free Radic Biol Med (2012) 0.99

Sedentary aging increases resting and exercise-induced intramuscular free radical formation. J Appl Physiol (1985) (2010) 0.99

Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation (2011) 0.98

The small chill: mild hypothermia for cardioprotection? Cardiovasc Res (2010) 0.97

Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules. Antioxid Redox Signal (2011) 0.97

Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy. J Pharmacol Exp Ther (2008) 0.97

The differential effects of superoxide anion, hydrogen peroxide and hydroxyl radical on cardiac mitochondrial oxidative phosphorylation. Free Radic Res (2007) 0.97

Rapid cooling preserves the ischaemic myocardium against mitochondrial damage and left ventricular dysfunction. Cardiovasc Res (2009) 0.96

Differential effects of postconditioning on myocardial stunning and infarction: a study in conscious dogs and anesthetized rabbits. Am J Physiol Heart Circ Physiol (2006) 0.96

Structure and pharmacology of swelling-sensitive chloride channels, I(Cl,swell). Fundam Clin Pharmacol (2003) 0.95

Intercostal and abdominal respiratory motoneurons in the neonatal rat spinal cord: spatiotemporal organization and responses to limb afferent stimulation. J Neurophysiol (2008) 0.95

Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist. FASEB J (2009) 0.94

Analysis of the inflammatory response induced by rhMMP-12 catalytic domain instilled in mouse airways. Int Immunopharmacol (2005) 0.94

Crystal structure of the open form of dog gastric lipase in complex with a phosphonate inhibitor. J Biol Chem (2001) 0.93

A safety grading scale to support dose escalation and define stopping rules for healthy subject first-entry-into-man studies: some points to consider from the French Club Phase I working group. Br J Clin Pharmacol (2010) 0.93

Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats. J Mol Cell Cardiol (2007) 0.93

Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemia. Am J Clin Nutr (2007) 0.92

Cervicolumbar coordination in mammalian quadrupedal locomotion: role of spinal thoracic circuitry and limb sensory inputs. J Neurosci (2012) 0.91

EPR spin trapping evaluation of ROS production in human fibroblasts exposed to cerium oxide nanoparticles: evidence for NADPH oxidase and mitochondrial stimulation. Chem Biol Interact (2012) 0.90

Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning. J Mol Cell Cardiol (2013) 0.90

Making the heart resistant to infarction: how can we further decrease infarct size? Front Biosci (2008) 0.90

Resveratrol protects against cold ischemia-warm reoxygenation-induced damages to mitochondria and cells in rat liver. Eur J Pharmacol (2005) 0.90

Effects of curcumin and curcumin derivatives on mitochondrial permeability transition pore. Free Radic Biol Med (2004) 0.89

Supplementation of the diet with the functional fiber PolyGlycoplex is well tolerated by healthy subjects in a clinical trial. Nutr J (2009) 0.88

Peripheral benzodiazepine receptor-induced myocardial protection is mediated by inhibition of mitochondrial membrane permeabilization. J Pharmacol Exp Ther (2007) 0.88

Prevention of heart failure in rats by trimetazidine treatment: a consequence of accelerated phospholipid turnover? J Pharmacol Exp Ther (2003) 0.88

Myocardial protection with mild hypothermia. Cardiovasc Res (2011) 0.86

Volume-sensitive chloride channels (ICl,vol) mediate doxorubicin-induced apoptosis through apoptotic volume decrease in cardiomyocytes. Fundam Clin Pharmacol (2004) 0.86

Defining survival as an outcome measure in amyotrophic lateral sclerosis. Arch Neurol (2009) 0.86

Ferulenol specifically inhibits succinate ubiquinone reductase at the level of the ubiquinone cycle. Biochem Biophys Res Commun (2007) 0.86

Absence of tumor suppressor tumor protein 53-induced nuclear protein 1 (TP53INP1) sensitizes mouse thymocytes and embryonic fibroblasts to redox-driven apoptosis. Antioxid Redox Signal (2011) 0.86

Spinal and pontine relay pathways mediating respiratory rhythm entrainment by limb proprioceptive inputs in the neonatal rat. J Neurosci (2012) 0.85

Oxidative stress, mitochondrial permeability transition pore opening and cell death during hypoxia-reoxygenation in adult cardiomyocytes. Eur J Pharmacol (2011) 0.85

The cardiac renin-angiotensin system is responsible for high-salt diet-induced left ventricular hypertrophy in mice. Eur J Heart Fail (2010) 0.85

Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure. J Nucl Med (2005) 0.85

Mild hypothermia reduces per-ischemic reactive oxygen species production and preserves mitochondrial respiratory complexes. Resuscitation (2012) 0.84

Preconditioning of salvaged myocardium in conscious rabbits with postinfarction dysfunction. Am J Physiol Heart Circ Physiol (2005) 0.84

Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease. PLoS One (2013) 0.84

Rapid cooling of the heart with total liquid ventilation prevents transmural myocardial infarction following prolonged ischemia in rabbits. Resuscitation (2010) 0.84

Protection of cellular and mitochondrial functions against liver ischemia by N-benzyl-N'-(2-hydroxy-3,4-dimethoxybenzyl)-piperazine (BHDP), a sigma1 ligand. Eur J Pharmacol (2007) 0.84

S-15176 inhibits mitochondrial permeability transition via a mechanism independent of its antioxidant properties. Eur J Pharmacol (2003) 0.84

Hypo-osmotic stress inhibits doxorubicin-induced apoptosis via a protein kinase A-dependent mechanism in cardiomyocytes. Clin Exp Pharmacol Physiol (2004) 0.84

DNA damage and oxidative stress induced by CeO2 nanoparticles in human dermal fibroblasts: Evidence of a clastogenic effect as a mechanism of genotoxicity. Nanotoxicology (2014) 0.83

The line asymmetry of electron spin resonance spectra as a tool to determine the cis:trans ratio for spin-trapping adducts of chiral pyrrolines N-oxides: the mechanism of formation of hydroxyl radical adducts of EMPO, DEPMPO, and DIPPMPO in the ischemic-reperfused rat liver. Free Radic Biol Med (2006) 0.83

Metalloelastase (MMP-12) induced inflammatory response in mice airways: effects of dexamethasone, rolipram and marimastat. Eur J Pharmacol (2006) 0.83

The volume-sensitive chloride channel inhibitors prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3kinase, Akt and Erk 1/2. Eur J Heart Fail (2008) 0.83

Conversion of post-systolic wall thickening into ejectional thickening by selective heart rate reduction during myocardial stunning. Eur Heart J (2007) 0.83

CORM-3, a water soluble CO-releasing molecule, uncouples mitochondrial respiration via interaction with the phosphate carrier. Biochim Biophys Acta (2013) 0.82

Pharmacokinetics in special populations. Drug Metab Rev (2009) 0.82

Evidence for sigma-1-like receptors in isolated rat liver mitochondrial membranes. Br J Pharmacol (2002) 0.82

Descending respiratory polysynaptic inputs to cervical and thoracic motoneurons diminish during early postnatal maturation in rat spinal cord. Eur J Neurosci (2005) 0.82

[Dihydropyridines from the first to the fourth generation: better effects and safety]. Therapie (2003) 0.81